Bentham Science Logo

Track Your Manuscript:

Cardiovascular & Hematological Disorders-Drug Targets

Formerly: Current Drug Targets - Cardiovascular & Hematological Disorders

Volume 21, 4 Issues, 2021
ISSN: 2212-4063 (Online)
ISSN: 1871-529X (Print)
This journal supports open access


Cardiovascular & Hematological Disorders-Drug Targets , Volume 18 - Number 2

Review Article

Sodium-glucose Cotransporter 2 Inhibitors: The Pleiotropic Mechanisms of Actions

, 18(2): 86 - 93

Panteleimon Pantelidis*, Andreas Kalliakmanis, Christos Mitas, Michail Sideris, Charalampos Grassos, Andreas Pittaras and Athanasios Manolis

DOI: 10.2174/1871529X18666180206130218

Review Article

Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic Agents

, 18(2): 94 - 103

Konstantinos Avranas*, Konstantinos Imprialos, Konstantinos Stavropoulos, Georgios Lales, Alexandos Manafis, Anastasia Skalkou and Lars Kihm

DOI: 10.2174/1871529X18666180206160838

Review Article

Sodium-glucose Cotransporter 2 Inhibitors: Impact on Body Weight and Blood Pressure Compared with other Antidiabetic Drugs

, 18(2): 104 - 113

Konstantinos P. Imprialos*, Konstantinos Stavropoulos, Nikiforos Stavropoulos, Dimitrios Patoulias, Konstantinos Petidis, Charalampos Grassos, Kyriakos Dimitriadis and Constantinos Tsioufis

DOI: 10.2174/1871529X18666180206144342

Review Article

Sodium-glucose Cotransporter 2 Inhibitors: Potential Cardiovascular and Mortality Benefits

, 18(2): 114 - 119

Dragan Lovic*, Andreas Pittaras, Manolis Kallistratos, Constantinos Tsioufis, Charalampos Grassos, Dragan Djordjevic, Ivan Tasic and Athanasios Manolis

DOI: 10.2174/1871529X18666180227102137

Review Article

Sodium-glucose Cotransporter 2 Inhibitors: Nephroprotective Impact on Diabetic Kidney Disease

, 18(2): 120 - 126

Konstantinos Stavropoulos*, Konstantinos P. Imprialos, Nikiforos Stavropoulos, Sofia Bouloukou, Georgios Kerpiniotis, Kyriakos Dimitriadis, Constantinos Tsioufis and Michael Doumas

DOI: 10.2174/1871529X18666180206155349

Review Article

Sodium-glucose Cotransporter 2 Inhibitors: The Impact on Development and Progression of Heart Failure

, 18(2): 127 - 133

Vasilios Papademetriou* and Eleni Geladari

DOI: 10.2174/1871529X18666180405102658

Review Article

Sodium-glucose Cotransporter 2 Inhibitors and Ischemic Stroke

, 18(2): 134 - 138

Dimitrios Milonas and Konstantinos Tziomalos*

DOI: 10.2174/1871529X18666180206120444

Review Article

Sodium-glucose Cotransporter 2 Inhibitors and the Risk of Diabetic Ketoacidosis; from Pathophysiology to Clinical Practice

, 18(2): 139 - 146

Dimitrios Patoulias*, Alexandros Manafis, Christos Mitas, Konstantinos Avranas, Georgios Lales, Ioanna Zografou, Christos Sambanis and Asterios Karagiannis

DOI: 10.2174/1871529X18666180206123149

General Review Article

What Genetics Tells us about Cardiovascular Disease in Diabetic Patients?

, 18(2): 147 - 152

Habib Haybar, Mohammad Taha Jalali and Zeinab Deris Zayeri*

DOI: 10.2174/1871529X18666180212114305

General Review Article

Platelet Activation Polymorphisms in Ischemia

, 18(2): 153 - 161

Habib Haybar, Elahe Khodadi, Kazem Zibara and Najmaldin Saki*

DOI: 10.2174/1871529X18666180326121239

Case Studies

A Rare Case of Tricuspid Valve Endocarditis Caused by Enterococcus Gallinarum in a Patient with Recurrent Urinary Tract Infection

, 18(2): 162 - 164

Tsipis Angelos*, Skandalakis Nikolaos, Kanakakis Nikolaos, Pilatis Nektarios and Petropoulou Evdokia

DOI: 10.2174/1871529X18666180302113428


Garry X. Shen
Department of Internal Medicine
University of Manitoba
Winnipeg, MB
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Cardiovascular and Hematological Disorders-drug Targets was launched in 2001. Dr. Garry X. Shen serves as the Editor-in-Chief of the journal.
New eBook

Frontiers in Clinical Drug Research-Hematology

You can view the contents of this eBook [here] or purchase it [here].

Related Journals

Related eBooks

eBooks Catalog